Carolina Oncology Specialists, PA

Hickory, North Carolina 28602

0 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Multiple Myeloma, Non Small Cell Lung Cancer (NSCLC), Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma

Studies at this site

• Connect® MM- The Multiple Myeloma Disease Registry — Stopped early
• Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma — Completed
• Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO — Completed
• ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer — Completed
• A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed
• A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer — Completed